Telangana: 3 kg of Ephedrine worth Rs 60 lakh seized, 2 held

Written By : Ruchika Sharma |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-08-13T11:30:36+05:30 | Updated On 13 Aug 2024 11:30 AM IST

Medical Aspirant Held for Submitting Fake NEET Scorecard.

Hyderabad: In a significant operation, the Directorate of Revenue Intelligence (DRI) Hyderabad Zonal Unit (HZU) has arrested two individuals and confiscated 3 kilograms of Ephedrine/Pseudoephedrine, with a value of Rs 60 lakh in the grey market.

The arrests came after DRI officers, acting on specific intelligence, intercepted the suspects on Friday in Hyderabad. The individuals were found attempting to courier a package destined for New Zealand. A meticulous examination led to the discovery of two vacuum-sealed transparent packets, according to a DRI statement issued on Saturday.

As per the UNI report, A white powdery substance found in both packets tested positive for Ephedrine/Pseudoephedrine using a field test kit. The 3 kg of Ephedrine/Pseudoephedrine, valued at Rs 60 lakh in the illicit market, was seized, and the two individuals were arrested under the provisions of the NDPS Act, 1985.

Ephedrine and Pseudoephedrine are classified as controlled substances under the Narcotic Drugs and Psychotropic Substances (NDPS) Act. These chemicals are precursors for the illicit manufacture of amphetamine and methamphetamine, collectively known as Amphetamine-Type Stimulants (ATS).

Further investigation is ongoing., the statement added.

Medical Dialogues team had earlier reported that the Gujarat Anti-Terrorist Squad (ATS) raided a mephedrone manufacturing unit in Thane district of neighbouring Maharashtra, seizing liquid drug valued at Rs 800 crore.

ephedrinepseudoephedrineamphetaminemethamphetamine

Source : with inputs

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751